GENE ONLINE|News &
Opinion
Blog

Keytruda
R&D Classical Hodgkin Lymphoma
Keytruda Outcompetes Adcetris in Refractory or Relapsed Hodgkin Lymphoma Study
2020-03-03
R&D Antibody-Drug Conjugate
Padcev Keytruda Combo Garners Breakthrough Therapy Designation for Urothelial Cancer
2020-02-20
Trials & Approvals Breast Cancer
Yet Another Feather in Merck’s Crown, Keytruda Meets Endpoint in Phase 3 Trial for Triple Negative Breast Cancer
2020-02-13
Trials & Approvals Pembrolizumab
Keytruda Flounders Lung Cancer Trial but Scores Key Win for Bladder Cancer
2020-01-14
Trials & Approvals Personalized Medicine
Rozlytrek Becomes the Third Tumor-Agnostic Medicine to be Approved by the USFDA
2019-08-21
M&A Immune Design
Merck set to acquire Tilos Therapeutics for $773 million
2019-06-12
Trials & Approvals Lung Cancer
Pembrolizumab Upstages Topline PD-1/L1 drugs in lung cancer tussle
2018-11-06
1 2 3
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top